European Journal of Immunology · 2006 · 80 citations · 56 references
Life SciencesCell BiologyImmunologyAutoimmunityCellular ImmunologyImmunopathologyCell-mediated ImmunityDendritic Cell BiologyDendritic Cell RegulationT Cell ActivationT Cell BiologyT Cell ToleranceAire-mediated Antigen PresentationAntigen Presenting CellsAutoimmune Polyendocrine Syndrome Type 1Autoimmune Polyendocrine SyndromesCell ActivationDendritic Cell-mediated T Cell ActivationNaive T CellsVascular Cell Adhesion Molecule 1
Patients with autoimmune polyendocrine syndrome type I (APS I)suffer from endocrine and non-endocrine disorders due to mutations in the autoimmune regulator gene (AIRE). Mouse Aire is expressed both in thymic medullary epithelial cells and in peripheral antigen-presenting cells, suggesting a role in both central and peripheral tolerance. We here report that Aire(-/-) dendritic cells (DC) activate naive T cells more efficiently than do Aire(+/+) DC. Expression array analyses of Aire(-/-) DC revealed differential regulation of 68 transcripts, among which, the vascular cell adhesion molecule-1 (VCAM-1) transcript was up-regulated in Aire(-/-) DC. Concurrently, the expression of the VCAM-1 protein was up-regulated on both Aire(-/-) DC and monocytes from APS I patients. Blocking the interaction of VCAM-1 prevented enhanced Aire(-/-) DC stimulation of T cell hybridomas. We determined an increased number of DC in spleen and lymph nodes and of monocytes in the blood from Aire(-/-) mice, and an increased number of blood monocytes in APS I patients. Our findings imply a role for Aire in peripheral DC regulation of T cell activation, and suggest that Aire participates in peripheral tolerance.
56
Projection of an Immunological Self Shadow Within the Thymus by the Aire Protein
Mark S. Anderson, Emily S. Venanzi, Ludger Klein et al. · Science · 2002 · 2.5K citations
Life Sciences, Genetics, Immunology +17
Positional cloning of the APECED gene
Kentaro Nagamine, Pärt Peterson, Hamish S. Scott et al. · Nature Genetics · 1997 · 1.4K citations
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
David H. Miller, Omar Khan, William Sheremata et al. · New England Journal of Medicine · 2003 · 1.2K citations · Full text